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ABSTRACT
Autologous mesenchymal stem cell (MSC) transplantation
therapy for repair of myocardial injury has inherent limita-
tions due to the poor viability of the stem cells after cell
transplantation. Adhesion is a prerequisite for cell survival and
also a key factor for the differentiation of MSCs. As a novel
prosurvival modification strategy, we genetically engineered
MSCs to overexpress tissue transglutaminase (tTG), with in-
tention to enhance adhesion and ultimately cell survival after
implantation. tTG-transfected MSCs (tTG-MSCs) showed a
2.7-fold and greater than a twofold increase of tTG expression
and surface tTG activity, respectively, leading to a 20% in-
creased adhesion of MSCs on fibronectin (Fn). Spreading and
migration of tTG-MSCs were increased 4.75% and 2.52%,
respectively. Adhesion of tTG-MSCs on cardiogel, a cardiac
fibroblast-derived three-dimensional matrix, showed a 33.1%
increase. Downregulation of tTG by transfection of small in-
terfering RNA specific to the tTG resulted in markedly de-
creased adhesion and spread of MSCs on Fn or cardiogel.
tTG-MSCs on Fn significantly increased phosphorylation of
focal adhesion related kinases FAK, Src, and PI3K. tTG-MSCs
showed significant retention in infarcted myocardium by form-
ing a focal adhesion complex and developed into cardiac myo-
cyte-like cells by the expression of cardiac-specific proteins.
Transplantation of 1 106 MSCs transduced with tTG into the
ischemic rat myocardium restored normalized systolic and
diastolic cardiac function. tTG-MSCs further restored cardiac
function of infarcted myocardium as compared with MSC
transplantation alone. These findings suggested that tTG may
play an important role in integrin-mediated adhesion of MSCs
in implanted tissues. STEM CELLS 2007;25:1431–1438
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INTRODUCTION
Under proper stimulation, mesenchymal stem cells (MSCs) can
be induced to differentiate into myocytes, adipocytes, osteo-
blasts, chondrocytes, tenocytes, and hematopoietic-supporting
stroma [1]. With recent reports that MSCs derived from bone
marrow can differentiate into cardiac muscle in vitro [2] and in
vivo [3], MSC autologous transplantation is a promising new
therapeutic modality for the repair of myocardial infarctions and
prevention of postinfarct congestive heart failure. However, in
experimental models, poor viability of the transplanted cells is a
major limiting factor of cell therapy. The survival rate of trans-
planted cells into an uninjured mouse heart was very low, 4 days
post transplantation [3]. This may require prosurvival strategies
to improve stem cell survival/number in the infarcted heart [4].
Although prosurvival strategies have been proven to be success-
ful in vitro, they actually may not solve the problems of poor
adhesion of MSCs.
Adhesion to structural glycoproteins of the extracellular
matrix (ECM) is necessary for survival of the differentiated
adherent cells in the cardiovascular system, including endothe-
lial cells, smooth muscle cells, fibroblasts, and cardiac myocytes
[5, 6] as well as differentiation of MSCs [7]. Adhesion of cells
to the matrix, predominantly via the integrin molecules, gener-
ates an endogenous tensile stress within the cells, called tenseg-
rity [8], and repression of apoptotic signals [9], whereas detach-
ment has the opposite effect. This physiological cellular process
may be necessary for MSC differentiation, survival, and growth.
Recently, tissue transglutaminase (tTG) on the cell surface and
in the ECM is reported to act as a coreceptor for fibronectin (Fn)
in cell adhesion associated with integrin [10, 11]. In this study,
as a novel prosurvival modification strategy, we genetically
engineered MSCs to overexpress tTG, with intentions to en-
hance adhesion and ultimately cell survival after implantation.
MATERIALS AND METHODS
Isolation and Culture of MSCs
MSCs were isolated from the femoral and tibial bones of rats [12].
Bone marrow-derived MSCs were collected from the aspirates of
the femurs and tibias of 4-week-old male Sprague-Dawley rats
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(approximately 100 g) with 10 ml of MSC medium consisting of
Dulbecco’s modified Eagle’s medium (DMEM)-low glucose, sup-
plemented with 10% fetal bovine serum and 1% antibiotic-penicillin
and streptomycin solution. Mononuclear cells recovered from the
interface after centrifugation in Percoll were washed twice, resus-
pended in 10% fetal bovine serum (FBS)-DMEM, and plated in
flasks at 1  106 cells per 100 cm2. Cultures were maintained at
37°C in a humidified atmosphere containing 5% CO2. After 48 or
72 hours, nonadherent cells were discarded, and the adherent cells
were thoroughly washed twice with phosphate-buffered saline
(PBS). Fresh complete medium was added and replaced every 3 or
4 days for approximately 10 days. To further purify the MSCs, the
Isolex Magnetic Cell Selection System (Baxter Healthcare Corpo-
ration, Irvine, CA, http://www.baxter.com) was used. Briefly, cells
were incubated with Dynabeads M-450 coated with anti-CD34
monoclonal antibody. A magnetic field was applied to the chamber
and the CD34 cell-bead complexes were separated magnetically
from the remaining cell suspension with the CD34 fraction being
further cultured. The cells were harvested after incubation with
0.25% trypsin and 1 mM EDTA for 5 minutes at 37°C, replated in
1 105/100-cm2 plates, and again grown for approximately 10
days. The characteristics of MSCs were demonstrated by immuno-
phenotyping. To verify the nature of cultured MSCs, cells were
labeled against various surface and intracellular markers and ana-
lyzed by flow cytometry. Cells were harvested, washed with PBS,
and labeled with the following antibodies conjugated with fluores-
cin isothiocyanate (FITC) or Texas Red: CD14, CD34, CD71,
CD90, CD105, and intracellular adhesion molecule (ICAM)-1.
FITC-conjugated goat anti-mouse IgG and Texas Red-conjugated
goat anti-rabbit IgG from Jackson Immunoresearch Laboratories
(West Grove, PA, http://www.jacksonimmuno.com) were used as
secondary antibodies. In the case of CD14, we used normal rabbit
IgG (SC-3888; Santa Cruz Biotechnology Inc., Santa Cruz, CA,
http://www.scbt.com) as a negative isotype control for flow cytom-
etry. Labeled cells were assayed by flow cytometry and analyzed
with CellQuest Pro software (Becton, Dickinson and Company,
Franklin Lakes, NJ, http://www.bd.com). To label viable MSCs
with 4,6-diamidino-2-phenylindole (DAPI), sterile DAPI solution
was added to the culture medium on the day of implantation at a
final concentration of 50 g/ml for 30 minutes. The cells were
rinsed six times in PBS to remove unbound DAPI, detached with
0.25% (wt/vol) trypsin, and suspended in serum-free medium for
grafting [13–15].
Transglutaminase Activity
Transglutaminase activity associated with the extracellular surface
was measured by the incorporation of biotinylated cadaverine into
Fn [16, 17]. For this assay, 2  105 cells per milliliter were plated
into 96-well plates precoated with plasma Fn in 100 l of complete
DMEM medium without serum in the presence of 0.1 mM biotin-
ylated cadaverine. As a negative control, Fn-coated 96-well plates
were incubated with 100 l of serum-free DMEM containing 0.1
mM biotinylated cadaverine alone. Cells were allowed to incubate
for 1 hour at 37°C, and then they were washed twice with PBS, pH
7.4, containing 3 mM EDTA, in order to stop the reaction. A
detergent solution (100 l) consisting of 0.1% (wt/vol) deoxy-
cholate in PBS, pH 7.4, containing 3 mM EDTA, was then added to
each well and the mixture incubated with gentle shaking for 20
minutes. The supernatant was discarded and the remaining Fn layer
washed three times with Tris-HCl, pH 7.4. Wells were then blocked
with 3% (wt/vol) bovine serum albumin (BSA; Sigma-Aldrich, St.
Louis, http://www.sigmaaldrich.com) in Tris-HCl buffer for 30
minutes at 37°C, washed with buffer, and then incorporated biotin-
ylated cadaverine revealed with a 1/5,000 dilution of ExtrAvidin
peroxidase conjugate (Sigma), which was incubated for 1 hour at
37°C using 3,3,5,5,-tetramethylbenzidine as a substrate. Color
development was stopped by adding 50 l of stop solution to each
well. The resulting color was then read in an enzyme-linked immu-
nosorbent assay plate reader at 450 nm.
Preparation of Cardiac Fibroblast-Derived Three-
Dimensional Matrix (Cardiogel)
Cardiogel was prepared with a minor modification [18]. Briefly,
2 105 cells per 35-mm dish were seeded and the medium changed
every 48 hours until the matrix was denuded of cells. The medium
was carefully aspirated and rinsed gently with PBS. Next, 1 ml of
prewarmed extraction buffer (0.5% Triton X-100, 20 mM NH4OH
in PBS) was added, and the process of cell lysis was observed using
an inverted microscope until no intact cells were visualized. The
cellular debris was washed with PBS, and the matrices were incu-
bated at 37°C for 30 minutes with 1 ml of DNase (10 units of DNase
per milliliter of PBS) to minimize the DNA debris. The matrix-
coated plates were covered with a minimum of 3 ml of PBS
containing 100 U/ml penicillin, 100 g/ml streptomycin, and 0.25
g/ml Fungizone for use afterward.
Immunoblot Analysis
Protein-treated cells were washed once in PBS and lysed in a lysis
buffer (Cell Signaling Technology, Beverly, MA, http://www.
cellsignal.com) containing 20 mM Tris (pH 7.5), 150 mM NaCl, 1
mM Na2-EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium pyro-
phosphate, 1 mM -glycerophosphate, 1 mM Na3VO4, 1 mg/ml
leupeptin, and 1 mM phenylmethylsulfonyl fluoride. Protein con-
centrations were determined using the Bradford Protein Assay Kit
(Bio-Rad, Hercules, CA, http://www.bio-rad.com). Proteins were
separated in a 12% sodium dodecyl sulfate-polyacrylamide gel and
transferred to polyvinylidene difluoride membrane (Millipore, Bil-
lerica, MA, http://www.millipore.com). After blocking the mem-
brane with Tris-buffered saline-Tween 20 (TBS-T, 0.1% Tween 20)
containing 5% nonfat dried milk for 1 hour at room temperature, the
membrane was washed twice with TBS-T and incubated with pri-
mary antibody for 1 hour at room temperature or overnight at 4°C.
The membrane was washed three times with TBS-T for 10 minutes
and then incubated for 1 hour at room temperature with horseradish
peroxidase-conjugated secondary antibodies. After extensive wash-
ing, the bands were detected by enhanced chemiluminescence re-
agent (Santa Cruz Biotechnology). The band intensities were quan-
tified using the Photo-Image System (Molecular Dynamics,
Sunnyvale, CA, http://www.mdyn.com).
Assays for Cell Adhesion, Spreading, and Migration
Four-well plates (Nunc, Rochester, NY, http://www.nuncbrand.
com) were coated with Fn (Sigma) for 24 hours at 4°C. Fn was
dissolved in PBS (pH 7.4) to yield a final concentration of 10
g/ml, and a volume of 150 l was added to the individual wells.
The plates were then blocked with 10 mg/ml BSA (Sigma) in PBS
for 1 hour at 37°C. MSCs either transfected with tTG (tTG-MSCs)
or not were isolated by trypsinization and were washed once in
DMEM with 10% FBS to stop trypsin activity and twice with
serum-free DMEM to remove serum components. Suspensions of
2  104 viable MSCs were then added to each well and allowed to
attach for 30 minutes at 37°C and 5% CO2. To determine MSC
adhesion, plates were carefully washed three times with PBS, and
then four separate fields were photographed by phase contrast
microscope. The number of attached cells was estimated by micro-
scopic cell counting using a hemacytometer. Each experiment was
performed in triplicate wells and repeated at least three times. For
spreading assays, MSCs were plated for 3 hours on either Fn-coated
or noncoated 4-well plates using the conditions of the adhesion
experiments described above. Plates were washed with PBS, fixed
with 3% formaldehyde, stained with Coomassie blue, destained, and
photographed. To determine MSC spreading, plates were carefully
washed three times with PBS, and then four separate fields were
photographed by phase contrast microscope. Migration was assayed
by a modification of the Boyden chamber method using microche-
motaxis chambers and polycarbonate filters (Nunc) with a pore size
of 8.0 m. The filters were coated with 10 g/ml Fn and placed
between the chambers. MSCs were trypsinized and suspended at a
concentration of 2  104 cells per milliliter in DMEM supple-
mented with 0.5% FBS. The MSC suspension (100 l) was placed
in the upper chamber, and 600 l of DMEM containing 5 ng/ml
basic fibroblast growth factor (bFGF) was placed in the lower
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chamber. The chamber was incubated at 37°C and 5% CO2 for 5
hours. The filter was then removed, and the cells on the upper side
of the filter were scraped off with a cotton tip. The MSCs that
migrated to the lower side of the filter were fixed in methanol and
stained with hematoxylin. The number of migrated cells was esti-
mated by microscopic cell counting using a hemacytometer. Exper-
iments were performed in triplicate and were repeated at least three
times.
Transfection and RNA Interference
Transient transfections of tTG cloned into the modified eukaryotic
expression vector pMT2 were performed using Lipofectamine PLUS
Reagent (Gibco-BRL, Gaithersburg, MD, http://www.gibcobrl.com)
[19]. Briefly, MSCs (second passage) cultured in a 60-mm culture plate
(3  105 cells per plate) were washed twice with serum-free DMEM.
Lipofectamine PLUS Reagent was diluted with serum-free DMEM and
combined with 5 g of DNA for each plate. The DNA and Lipo-
fectamine PLUS Reagent were added into each plate containing fresh
medium on cells. After 12 hours of incubation in a CO2 incubator at
37°C, the medium was exchanged with 10% FBS-DMEM. The cells
were further incubated for 24 hours at 37°C. For function-blocking
experiments, small interfering (si)RNA molecules were targeted at tTG
mRNA. A 21-nucleotide sequence for siRNA was derived from the
human tissue transglutaminase mRNA sequence (GenBank accession
number GI: 42476286) and obtained from Ambion (Austin, TX, http://
www.ambion.com). siRNA against tTG (sense, 5-GGGUUACCGGA
AU AUCAUCTT-3; antisense, 5-GAUGAUAUUCCGGUAACCCT
T-3)and silencer negative control siRNA were also designed and
synthesized by Ambion. MSCs were transfected with si-tTG duplexes
by using siPORT NeoFX (Ambion). Briefly, RNA duplex (10 nM final
concentration) was incubated in serum-free DMEM containing 15l of
siPORT NeoFX for 10 minutes. The complex was added to the empty
60-mm culture plate and overlaid with a MSC suspension (1  105
cells per plate) onto the culture plate wells containing transfection
complexes. The transfected cells were incubated in normal cell culture
conditions until ready to assay.
Induction of Myocardial Infarction and
Transplantation
All experimental procedures for animal studies were approved by
the Committee for the Care and Use of Laboratory Animals, Yonsei
University College of Medicine, and performed in accordance with
the Committee’s Guidelines and Regulations for Animal Care.
Myocardial infarction was produced in male Sprague-Dawley rats
(200  30 g) by surgical occlusion of the left anterior descending
coronary artery, according to previously described procedures [20].
Briefly, after induction of anesthesia with ketamine (10 mg/kg) and
xylazine (5 mg/kg), cutting the third and fourth ribs opened the
chest, and the heart was exteriorized through the intercostal space.
The left coronary artery was ligated 2–3 mm from its origin with a
5-0 prolene suture (ETHICON, Somerville, NJ, http://www.ethicon.
com) for 3 days. For transplantation, cells were suspended in 10 l
of serum-free medium (1  106 cells) and injected from the injured
region to the border using a Hamilton syringe (Hamilton Co., Reno,
NV, http://www.hamiltoncompany.com) with a 30-gauge needle.
Throughout the operation, animals were ventilated with 95% O2 and
5% CO2 using a Harvard ventilator. Operative mortality was 10%
within 48 hours. Eight animals per group (ligation, MSCs, mock-
MSCs, tTG-MSCs) were used for morphologic analysis at 1 week
after occlusion of left coronary artery. For functional studies, we
used eight animals per group for echocardiography at 3 weeks after
occlusion. To label MSCs with DAPI for viable cells, sterile DAPI
solution was added into the culture medium on the day of implan-
tation at a final concentration of 50 g/ml. The dye was allowed to
remain in the culture dishes for 30 minutes. The cells were rinsed
six times in PBS to remove all excess and unbound DAPI. Labeled
cells were then detached with 0.25% (wt/vol) trypsin and suspended
in serum-free medium for grafting.
Histology and Immunohistochemistry
Transplants were killed at several intervals after implantation, and
their hearts were excised. The heart was perfusion-fixed with 10%
(vol/vol) neutral buffered formaldehyde for 24 hours, transversely
sectioned into four comparably thick sections, and embedded in
paraffin by routine methods. Sections of 2-m thickness were
mounted on gelatin-coated glass slides to ensure different stains
could be used on successive sections of tissue cut through the
implantation area. After deparaffinization and rehydration, the sec-
tions were stained with hematoxylin and eosin to assess cytologic
details such as nuclei, cytoplasm, and connective tissue. Addition-
ally, fibrosis was analyzed by Masson’s Trichrome staining. Other
serial sections were analyzed with mouse anti-major histocompati-
bility complex (MHC), mouse anti-myosin light chain (MLC),
mouse anti-cardiac troponin T (CTn T) obtained from Santa Cruz
Biotechnology, rabbit anti-Ca2 channel (Cav2.1) from Alomone
Labs (Jerusalem, http://www.alomone.com), and rabbit anti-con-
nexin 43 and rabbit anti-N-cadherin from Cell Signaling Technol-
ogy. FITC-conjugated goat anti-rabbit IgG and Texas Red-conju-
gated goat anti-mouse IgG or mouse anti-goat IgG from Jackson
Immunoresearch Laboratories were used as secondary antibodies.
All images were made by using an excitation filter under reflected
light fluorescence microscopy and transferred to a computer
equipped with MetaMorph software version 4.6 (Universal Imaging
Corp., Downtown, PA, http://www.universal-imaging.com).
Assessment of Cardiac Function
Transthoracic echocardiographic studies were performed by an ex-
perienced cardiologist who was blinded to the group to which the
animals had been allocated at baseline (before left anterior de-
scending coronary artery [LAD] ligation), immediately after LAD
ligation (before treatment), and 3 weeks after cell transplantation
(after treatment) on a GE Vivid Seven ultrasound machine (GE
Healthcare, New York, http://www.gehealthcare.com/usen/index.
html) with a 10.0 MHz transducer. The rats were anesthetized
generally and placed in the left lateral decubitus position. The
echo transducer was placed on the left hemithorax, and short axis
views were recorded. Two-dimensional (2D) images were obtained
at midpapillary level [21, 22]. The M-mode tracing of left ven-
tricular (LV) contraction was also obtained at the same level as
the short-axis view. LV end diastolic diameter (LVEDD) and LV
end systolic diameter (LVESD) were measured with the M-mode
tracing. Percent fractional shortening was determined as
([LVEDD  LVESD]/LVEDD)  100 (%). LV end diastolic
volume (LVEDV) was calculated as 7.0  LVEDD3/(2.4 
LVEDD), LV end systolic volume (LVESV) as 7.0 LVESD3/(2.4
 LVESD), and LV ejection fraction (EF) as EF (%) (LVEDV
LVESV)/LVEDV  100. Two images were obtained in each view,
and each parameter was measured from three consecutive beats in
each image. Six values of each parameter were measured, and the
average was recorded. Echocardiograms were stored digitally and
analyzed offline with the EchoPAC program with custom 2D strain
rate imaging software. More than three images were obtained in the
short axis view, and the parameters were measured from three
consecutive beats in each image. For the quantitative analysis of
regional LV systolic function, peak systolic circumferential strain
and peak systolic radial strain were measured on six segments
(anteroseptum, anterior, anterolateral, posterolateral, inferior, in-
feroseptum) of the mid-LV level in the parasternal short-axis view.
For quantitative analysis of global LV systolic function, the average
values of peak systolic circumferential and that of peak systolic
radial strain of the six segments were calculated.
Statistical Analysis
All data were expressed as means  SD. We considered p values
less than .05 statistically significant (analysis of variance and Stu-
dent’s t test).
RESULTS
Isolation and Characteristics of MSCs and
Transfection of tTG into MSCs
MSCs were first isolated from mixed cultures with hematopoi-
etic cells based on their attachment on the culture plate. The
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isolated MSCs were further purified using bead targeting the
hematopoietic marker CD34, yielding 3  106 cells within 2
weeks of culture with 95% purity. The MSCs retained a fibro-
blastic morphology through repeated passages, and their identity
was confirmed by immunocytochemistry and fluorescence-acti-
vated cell sorting (FACS) analysis. The cultured MSCs ex-
pressed CD71, CD90, CD105, CD106, and ICAM. They ex-
pressed neither the hematopoietic marker CD34 nor CD14 (Fig.
1A). The tTG gene was introduced into the MSCs using Lipo-
fectamine PLUS, and cells harboring the tTG gene were col-
lected by FACS to implant into infarcted myocardium. Overex-
pression of tTG led to a 2.7-fold increase in the cellular tTG
content in the tTG-transfected MSCs as compared with the
vector-transfected MSCs. The surface tTG activity also showed
an approximate 2- to 2.5-fold increase in tTG-transfected MSCs
(Fig. 1B). Introduction of siRNA molecules for tTG into MSCs
significantly decreased both in protein level of tTG and in
surface tTG activity.
tTG-Mediated Adhesion, Spreading, and Migration
of MSCs
To determine the effect of overexpressed tTG in adhesion of
MSCs, we performed quantitative adhesion assays with tTG-
MSCs. As shown in Figure 2A, adhesion of MSCs to Fn-coated
Figure 1. The characteristics of MSCs and expression of tTG. (A):
Most adherent MSCs are practically fibroblastic in morphology, and
some polygonal cells were contained after a 6-week culture. Magnifi-
cation, 100. Cells were cultured from bone marrow after density
fractionation and are shown at 10 days after plating. At 14 days, the
MSCs were positive for CD71, CD90, CD105, CD106, and intracellular
adhesion molecule-1 and were negative for CD14 and CD34 by flow
cytometry. (B): Expression levels of cellular tTG were determined by
immunoblot with anti-tTG antibody, and relative amounts were esti-
mated using densitometry. Activity of surface tTG was determined
using cell-mediated incorporation of biotinylated cadaverine into fi-
bronectin (Fn). MSCs were plated (2  105 cells per well) in complete
Dulbecco’s modified Eagle’s medium without serum in the presence of
0.1 mM biotinylated cadaverine. Cells were allowed to incubate in the
Fn-coated plates for 1 hour at 37°C, and the reaction was stopped by
washing cells with phosphate-buffered saline containing 3 mM EDTA.
Color development was determined by using an enzyme-linked immu-
nosorbent assay plate reader set to 450 nm. Each point represents the
mean value obtained in three experiments done in duplicate. , p  .05.
Abbreviations: tTG, tissue transglutaminase; tTG-MSCs, tissue trans-
glutaminase-transfected MSCs; tTGRNAi, tissue transglutaminase RNA
interference.
Figure 2. Tissue transglutaminase (tTG)-dependent adhesion, spread-
ing, and migration of MSCs. Quantitative adhesion (A) and spreading
assays (B) with MSCs and tTG-MSCs were measured on fibronectin
(Fn)-coated plates for 30 minutes and 3 hours, respectively. Function
blocking of tTG was conducted with transfection of small interfering
RNA molecules specific for tTG mRNA. (C): Migration assays of
MSCs and tTG-MSCs were conducted using a Boyden transwell cham-
ber with Fn-coated transmembrane for 5 hours, and bFGF (5 ng/ml) was
used as a migration stimulating chemoattractant. Data were expressed as
percentage of supplement of 2  104 cells per well, which represented
100% and represented the mean value obtained in three experiments
done in duplicate. The mean attachment values  SD on Fn were
5,012  52 in MSCs and 9,025  28 in tTG-MSCs. The mean values
of spread cells were 380  19 in MSCs and 1,330  38 in tTG-MSCs,
and the mean values of migrated cells were 1,404  61 in MSCs and
1,908  35 in tTG-MSCs after addition of bFGF as a chemoattractant.
, p  .05; , p  .01. Abbreviations: bFGF, basic fibroblast growth
factor; NS, no spreading; S, spreading; tTG-MSCs, tissue transglutami-
nase-transfected MSCs; tTGRNAi, tissue transglutaminase RNA
interference.
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culture plastic surfaces was enhanced approximately 20% by
tTG introduction. To further evaluate the adhesive function of
tTG, we cointroduced siRNA molecules for tTG with or without
the tTG vector into MSCs. We observed markedly decreased
adhesion lower than that of controls in both MSCs and tTG-
MSCs. More spreading cells appeared in the tTG-MSC cultures
than in the control MSC cultures at the indicated time (typically
to 4.75% of control values). Introduction of siRNA molecules
for tTG into MSCs also significantly decreased the number of
spreading cells to a control level (Fig. 2B). To test the involve-
ment of surface tTG in migration of MSCs with bFGF as a
chemoattractant, we used transmigration assays with Transwells
(Corning Life Sciences, Acton, MA, http://www.corning.com/
lifesciences) where the undersurface was coated with Fn. tTG-
MSCs exhibited a 2.52% greater transmigration onto Fn-coated
membrane than control MSCs (Fig. 2C).
tTG-Dependent Adhesion of MSCs on Cardiac
Fibroblast-Derived Three-Dimensional Matrix
(Cardiogel)
We further examined the adhesion of MSCs on cardiogel be-
cause three-dimensional (3D) matrix interactions display more
biological activities relevant to living organisms in comparison
to 2D surfaces coated with Fn. These distinctive in vivo 3D
matrix adhesions differ in structure, localization, and function
from classically described in vitro adhesions [18]. The cell
adhesion to cardiogel was significantly increased in both cases
of tTG-MSCs and control MSCs as compared with adhesion to
flat plates in spite of Fn coating. The adhesive difference be-
tween MSCs and tTG-MSCs was over 33.1% greater when
prepared on cardiogel as compared with the Fn-coated flat plates
(Fig. 3A).
Effect of tTG Overexpression on the Adhesion-
Related Signals in MSCs
It is well established that integrin activates the cellular focal
adhesion-related kinases FAK, Src, and PI3K at the adhesive
stage and acts, along with tTG protein, as a coreceptor of
integrin. Therefore, we investigated the effect of overexpression
of tTG in MSCs on the expression of the above-mentioned three
proteins at the early adhesive stage. Overexpression of tTG
significantly increased the phosphorylation of all three kinases,
suggesting that transfection of tTG has a significant effect on the
adhesive mechanisms of MSCs (Fig. 3B).
Immunohistochemistry and Histologic Analysis
To address the effect of tTG-MSCs in vivo, we transplanted
tTG-MSCs labeled with DAPI into the border region between
the infarcted area and the normal area. After 3 days, we dis-
sected implants of infarcted myocardium by 2-m thickness.
tTG-MSCs were retained in approximately 750 cells per section
compared with MSCs only in approximately 280 cells per
section (Fig. 4A). At 1 week after coronary ligation, the size of
left ventricular infarct was recovered both in MSCs and tTG-
MSCs compared with the control, but the degree of fibrosis of
the infarct zone was higher in MSCs compared with tTG-MSCs
(Fig. 4B). After 4 weeks, H&E staining of implants in infarcted
myocardium showed alignment of tTG-MSCs with host cardi-
omyocytes in the DAPI-stained regions, indicating that DAPI-
labeled donor cells were incorporated into the nonlabeled cell
(host cardiomyocytes). To confirm that the implanted cells had
formed cardiac myocyte-like cells, immunohistochemistry was
performed and showed that the cardiac-specific markers CTn T,
MHC, MLC, and Cav2.1 were detectable in the regions that
were DAPI-stained. DAPI-stained tTG-MSCs also expressed
connexin-43 and N-cadherin at the regions with the host cardi-
omyocytes (Fig. 4C).
Evaluation of Cardiac Function
Cardiac dimensions and performance parameters were measured
by transthoracic echocardiography. At baseline (i.e., after in-
farction and before cell transplantation), echocardiographic pa-
rameters were not different between the groups. As Figure 5
shows, transplantation of MSCs decreased cardiac dimension
and improved systolic performance as compared with the con-
trol. Transplantation of tTG-MSCs resulted in a further decrease
in the left ventricular chamber size (16.4% decrease in LV end
diastolic diameter and 39.1% decrease in LV end diastolic
volume) and a further improvement of LV systolic function
(66.1% increase in fractional shortening and 46.4% increase in
Figure 3. Tissue transglutaminase (tTG)-dependent adhesion of MSCs
and integrin-mediated adhesion-related signals on cardiac fibroblast-
derived three-dimensional matrix. (A): tTG-MSCs were plated on car-
diogel for 3 hours. Function blocking of tTG was conducted with
transfection of small interfering RNA molecules specific for tTG. Data
were expressed as percentage of supplement of 2  104 cells per well,
which represented 100% and represented the mean value obtained in
three experiments done in duplicate. The mean attachment values  SD
on cardiogel were 11,200  142 in MSCs and 17,825  228 in
tTG-MSCs. (B): Activation of these proteins was enhanced at the
adhesive state of tTG-MSCs on Fn as compared with MSCs. MSCs or
tTG-MSCs (1  106) were plated on Fn-coated 60 Ø plates. Activation
levels and total levels of each protein were determined after plating and
incubating for 3 hours. The phosphorylated states or total expressions of
each protein were monitored by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis followed by immunoblot analysis with antibodies
specific for ERK1/2, FAK, p-FAK, PI3K, p-PI3K, Src, and p-Src. The
band intensities were quantified using the Photo-Image System, and
each point represented the mean value obtained in three experiments. ,
p  .05; , p  .01. Abbreviations: a.u., arbitrary unit; Fn, fibronectin;
tTG-MSCs, tissue transglutaminase-transfected MSCs.
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ejection fraction) as compared with the MSC group. The peak
circumferential and radial strain in the infarct zone and global
LV were improved in the MSC group as compared with the
control. These parameters assessed by 2D strain rate imaging
were also further improved in the tTG-MSC group as compared
with the MSC group (Table 1).
DISCUSSION
In this study, we have demonstrated that tTG enhances adhe-
siveness of MSCs into a matrix and spreading and migration of
MSCs and enhances the assembly of focal adhesion complexes
in vitro. Moreover, tTG-MSCs further restore cardiac function
of infarcted myocardium as compared with MSC transplantation
alone.
In cell implantation studies for cardiac infarction, several
cell types, including skeletal myoblasts [23–25], cardiac myo-
cytes (adult, fetal, or neonatal myocytes) [26, 27], and embry-
onic stem cell-derived cardiac myocytes [12], were investigated,
but each cell therapy appears to have clinical limitations. Au-
tologous MSCs have a great advantage to generate functional
cardiac myocytes in the infarcted myocardium because of the
easy preparation from adult patients and immunologic safety.
However, the frequency of MSC engraftment was extremely
low despite implanting large numbers of cells because of a poor
rate of cell adhesion and survival. Recently, in a new approach
to enhancing the viability of MSCs, they were exposed to the
survival signal Akt in the early post-transplant period [28]. Even
though the mechanisms of stem cell therapy appear to be far
more complex, it has been suggested that stem cells protect
cardiomyocytes from apoptotic cell death, release angiogenic
ligands, induce proliferation of endogenous cardiomyocytes,
and may recruit resident cardiac stem cells [29–32].
Figure 4. Analysis of myocardial repair after implantation into in-
farcted myocardium. (A): Engraftment was significantly improved with
tissue transglutaminase (tTG) overexpression at 3 days after injection of
DAPI-stained cells (1  106). (B): Masson’s Trichrome stain of in-
fracted region resulted in a blue coloration of the fibrotic areas and
muscle tissue appeared orange/brown. (C): H&E staining demonstrates
the infiltration of viable, mature cardiac myocytes from the border zone
into the scar area and infiltrated viable cells lighted with DAPI at 4
weeks after implantation. Immunohistochemical staining showed the
cardiac-specific markers CTn T, MHC, MLC, and Cav2.1 were ex-
pressed in the DAPI-labeled cells. Merged images of DAPI (blue) and
double staining of sections for connexin-43 or N-cadherin (green) and
Cav2.1 and CTn T (red) demonstrated that MSC-derived cardiac myo-
cytes express connexin-43 and N-cadherin in the contact surface to the
host myocytes. , p  .05. Abbreviations: Cav2.1, rabbit anti-Ca2
channel; CTn T, cardiac troponin T; Cx43, connexin-43; DAPI, 4,6-
diamidino-2-phenylindole; MHC, major histocompatibility complex;
MLC, myosin light chain; tTG-MSCs, tissue transglutaminase-trans-
fected MSCs.
Figure 5. Cardiac function measured with two-dimensional strain
imaging. Representative images for control, MSC, mock-MSC, and
tTG-MSC groups. The M-mode tracing of left ventricular (LV) contrac-
tion was also obtained at the same level as the short-axis view. LV end
diastolic diameter (LVEDD) and LV end systolic diameter (LVESD)
were measured with the M-mode tracing. Percent fractional shortening
was determined as ([LVEDD  LVESD]/LVEDD)  100 (%). LV end
diastolic volume (LVEDV) was calculated as 7.0  LVEDD3/(2.4 
LVEDD), LV end systolic volume (LVESV) as 7.0  LVESD3/(2.4 
LVESD), and LV ejection fraction (EF) as EF (%)  (LVEDV 
LVESV)/LVEDV  100. Abbreviation: tTG-MSCs, tissue transglu-
taminase-transfected MSCs.
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The absence of adhesion and spreading is probably the main
cause of poor cell survival in cell transplantation [33, 34]. The
causes of cell death are influenced by the ischemic environment,
which is devoid of nutrients and oxygen, coupled with the loss
of survival signals from inadequate interaction between cells
and matrix [5]. Therefore, enhancement of cell adhesion and
spreading should be one of the major aims in the development
of cell transplantation techniques, including the therapeutic use
of progenitor cells. Although the adhesion is mainly mediated
by integrin v3 and the 1 family integrin 51 [35], tTG
enhances adhesion by acting as a bridge between integrins and
Fn or by mediating the formation of ternary complexes where
all three proteins interact with each other [11]. The purpose of
this in vitro study was to confirm the role of tTG on adhesion,
spreading, and migration of MSCs and the effect on cellular
signals. Based on our observation, tTG-MSCs showed a sig-
nificant increase in adhesion and spreading and a relatively
minor increase in migration. In addition, we observed that
phosphorylation of focal adhesion-related kinases including FAK,
Src, and PI3K was significantly increased. We also confirmed
an increase in the phosphorylation level of extracellular signal-
regulated kinases, which are a major signal mediator of cell pro-
liferation.
siRNA molecules were used against tTG to reduce tTG
expression. In these function-blocking experiments, adhesion
and spreading of MSCs were both markedly reduced. Our
results show siRNA molecules for tTG can reduce the ability
of MSCs to adhere and spread on Fn, suggesting that cell
surface tTG may have an important cell-binding role on the
ECM of infarcted myocardium after transplantation. Accord-
ing to transthoracic echocardiography, transplantation of
tTG-MSCs resulted in a further decrease in LV chamber size
and a further improvement of LV systolic function in the
MSC group. Finally, we suggest that genetic modification of
MSCs with tTG increases adhesiveness on the ECM of in-
farcted myocardium, overcoming the problem of cell death
after implantation.
CONCLUSION
Autologous mesenchymal stem cell transplantation therapy for
tissue repair has inherent limitations due to the poor viability of
the stem cells after cell transplantation. Adhesion is a prerequi-
site for cell survival and also a key factor for the differentiation
of MSCs. As a novel prosurvival modification strategy, we
genetically engineered MSCs to overexpress tissue transglu-
taminase, with intention to enhance adhesion and ultimately cell
survival after implantation. tTG-transfected MSCs enhanced
cell adhesiveness, including spreading and migration into a
matrix as well as enhancing the assembly of focal adhesion
complexes in vitro. tTG-MSCs further restored cardiac function
of infarcted myocardium as compared with MSC transplantation
alone. These findings suggest that tTG may play an important
role in integrin-mediated adhesion of MSCs in implanted tis-
sues.
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